AR098825A1 - PHARMACEUTICAL OR COSMETIC COMPOSITIONS FOR TOPICAL USE THAT INCLUDE OCTENIDINE DIHYDROCLORIDE - Google Patents
PHARMACEUTICAL OR COSMETIC COMPOSITIONS FOR TOPICAL USE THAT INCLUDE OCTENIDINE DIHYDROCLORIDEInfo
- Publication number
- AR098825A1 AR098825A1 ARP140104753A ARP140104753A AR098825A1 AR 098825 A1 AR098825 A1 AR 098825A1 AR P140104753 A ARP140104753 A AR P140104753A AR P140104753 A ARP140104753 A AR P140104753A AR 098825 A1 AR098825 A1 AR 098825A1
- Authority
- AR
- Argentina
- Prior art keywords
- weight
- composition
- glycol
- skin
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Se describen composiciones farmacéuticas o cosméticas para use tópico que comprenden dihidrocloruro de octenidina. Dichas composiciones son estables y se pueden aplicar de modo fácil y seguro sobre zonas extensas de la piel con buena aceptación por los pacientes en general para el tratamiento o la prevención de algunos trastornos o enfermedades de la piel. Reivindicación 1: Una composición farmacéutica o tópica, que comprende: (a) 0,01 - 3,0% en peso de dihidrocloruro de octenidina; (b) 1 - 20% en peso de al menos un hidrocarburo derivado del petróleo; (c) 0,5 - 10% en peso de al menos un triglicérido de ácido graso C₆₋₂₄; (d) 1 - 20 % en peso de al menos un alcohol graso C₆₋₂₄; (e) 1 - 15% en peso de al menos un tensioactivo no iónico; (f) 1 a 20% en peso de al menos un poliol; y (g) 30 - 70% en peso de agua. Reivindicación 10: Una composición según la reivindicación 1, que comprende referido al peso total de la composición: (a) 0,01 - 3,0% en peso de dihidrocloruro de octenidina; (b) 1 - 20% en peso de al menos un hidrocarburo derivado del petróleo seleccionado de parafina dura, parafina líquida, parafina líquida ligera, parafina blanda blanca y mezclas de los mismos; (c) 0,5 - 10% en peso de al menos un triglicérido de ácido graso C₆₋₂₄; (d) 1 - 20% en peso de al menos un alcohol graso C₆₋₂₄; (e) 1 - 15 % en peso de al menos un tensioactivo no iónico seleccionado de mono- y di-glicéridos, ésteres de etilenglicol o propilenglicol con ácidos grasos C₆₋₂₂, éteres alquílicos de polioxietileno, ésteres de ácidos grasos de polioxietilensorbitán, diacetato de propilenglicol, ésteres de sorbitán, y mezclas de los mismos; (f) 1 a 20% en peso de al menos un poliol seleccionado de etilenglicol, propilenglicol, 1,3-butilenglicol, 1,4-butilenglicol, hexilenglicol, dipropilenglicol, polietilenglicol con pesos moleculares medios ponderales que varían entre 100 y 1000, glicerol, poliglicerol y mezclas de los mismos; y (g) 30 - 70% en peso de agua. Reivindicación 13: Una composición de acuerdo con una cualquiera de las reivindicaciones precedentes, en donde la composición está formulada en forma de una crema, un gel, una pomada, una pasta, una suspensión, una loción, una espuma, un spray, un aerosol o una solución. Reivindicación 14: Una composición como se ha definido en una cualquiera de las reivindicaciones 1 a 13, para uso en el tratamiento o la prevención de enfermedades o trastornos de la piel seleccionados de eczema infectado (dermatitis infectada), infecciones bacterianas cutáneas o infecciones fúngicas cutáneas. Reivindicación 16: Método para tratar a un sujeto aquejado de trastornos o enfermedades de la piel definidas en la reivindicación 14, que comprende aplicar a la superficie afectada de la piel de dicho sujeto una cantidad eficaz de una composición como se ha definido en una cualquiera de las reivindicaciones 1 a 13.Pharmaceutical or cosmetic compositions are described for topical use comprising octenidine dihydrochloride. Such compositions are stable and can be applied easily and safely over large areas of the skin with good acceptance by patients in general for the treatment or prevention of some skin disorders or diseases. Claim 1: A pharmaceutical or topical composition, comprising: (a) 0.01-3.0% by weight of octenidine dihydrochloride; (b) 1-20% by weight of at least one petroleum-derived hydrocarbon; (c) 0.5-10% by weight of at least one C₆₋₂₄ fatty acid triglyceride; (d) 1-20% by weight of at least one C₆₋₂₄ fatty alcohol; (e) 1-15% by weight of at least one non-ionic surfactant; (f) 1 to 20% by weight of at least one polyol; and (g) 30-70% by weight of water. Claim 10: A composition according to claim 1, comprising referring to the total weight of the composition: (a) 0.01-3.0% by weight of octenidine dihydrochloride; (b) 1-20% by weight of at least one petroleum hydrocarbon selected from hard paraffin, liquid paraffin, light liquid paraffin, white soft paraffin and mixtures thereof; (c) 0.5-10% by weight of at least one C₆₋₂₄ fatty acid triglyceride; (d) 1-20% by weight of at least one C₆₋₂₄ fatty alcohol; (e) 1-15% by weight of at least one non-ionic surfactant selected from mono- and di-glycerides, ethylene glycol or propylene glycol esters with C₆₋₂₂ fatty acids, polyoxyethylene alkyl ethers, polyoxyethylene sorbitan fatty acid esters, diacetate of propylene glycol, sorbitan esters, and mixtures thereof; (f) 1 to 20% by weight of at least one polyol selected from ethylene glycol, propylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, hexylene glycol, dipropylene glycol, polyethylene glycol with weight average molecular weights varying between 100 and 1000, glycerol , polyglycerol and mixtures thereof; and (g) 30-70% by weight of water. Claim 13: A composition according to any one of the preceding claims, wherein the composition is formulated in the form of a cream, a gel, an ointment, a paste, a suspension, a lotion, a foam, a spray, an aerosol or a solution. Claim 14: A composition as defined in any one of claims 1 to 13, for use in the treatment or prevention of diseases or disorders of the skin selected from infected eczema (infected dermatitis), bacterial skin infections or fungal skin infections . Claim 16: Method for treating a subject afflicted with skin disorders or diseases defined in claim 14, which comprises applying to the affected skin surface of said subject an effective amount of a composition as defined in any one of claims 1 to 13.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13382521 | 2013-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR098825A1 true AR098825A1 (en) | 2016-06-15 |
Family
ID=49876522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP140104753A AR098825A1 (en) | 2013-12-18 | 2014-12-18 | PHARMACEUTICAL OR COSMETIC COMPOSITIONS FOR TOPICAL USE THAT INCLUDE OCTENIDINE DIHYDROCLORIDE |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3082753A1 (en) |
AR (1) | AR098825A1 (en) |
TW (1) | TW201605444A (en) |
WO (1) | WO2015091692A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10264788B2 (en) * | 2015-12-30 | 2019-04-23 | Carefusion 2200, Inc. | Antimicrobial wipe |
US20230060820A1 (en) * | 2019-12-31 | 2023-03-02 | 3M Innovative Properties Company | Octenidine salt antimicrobial medical articles |
EP3981402A4 (en) * | 2020-08-14 | 2022-08-10 | BL&H Co., Ltd. | Pharmaceutical composition for prevention or treatment of tinea |
KR102217617B1 (en) * | 2020-08-14 | 2021-02-19 | 비엘엔에이치 주식회사 | Pharmaceutical composition for preventing or treating tinea |
DE102020214352A1 (en) | 2020-11-16 | 2022-05-19 | Beiersdorf Aktiengesellschaft | Pump spray with deodorants |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3584236D1 (en) * | 1984-12-12 | 1991-10-31 | Euro Celtique Sa | ANTIBACTERIAL CREAM. |
DE102005063375A1 (en) | 2005-09-15 | 2007-04-19 | Schülke & Mayr GmbH | Antimicrobial preparations containing octenidine dihydrochloride encapsulated in liposomes |
DE102005045145A1 (en) | 2005-09-15 | 2007-03-29 | Schülke & Mayr GmbH | Use of octenidine dihydrochloride in semisolid preparations |
DE102010044785A1 (en) | 2010-09-09 | 2012-03-15 | Beiersdorf Ag | Octenidine dihydrochloride as a coemulsifier in microemulsions |
DE102010044787A1 (en) | 2010-09-09 | 2012-03-15 | Beiersdorf Ag | Macroemulsions with improved deodorant activity |
-
2014
- 2014-12-12 TW TW103143550A patent/TW201605444A/en unknown
- 2014-12-17 EP EP14816228.2A patent/EP3082753A1/en not_active Withdrawn
- 2014-12-17 WO PCT/EP2014/078303 patent/WO2015091692A1/en active Application Filing
- 2014-12-18 AR ARP140104753A patent/AR098825A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW201605444A (en) | 2016-02-16 |
WO2015091692A1 (en) | 2015-06-25 |
EP3082753A1 (en) | 2016-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR098825A1 (en) | PHARMACEUTICAL OR COSMETIC COMPOSITIONS FOR TOPICAL USE THAT INCLUDE OCTENIDINE DIHYDROCLORIDE | |
BR112018011558A2 (en) | composition, cosmetic use of a composition, cosmetic process for treating keratin materials and cosmetic treatment process | |
CL2017002432A1 (en) | Composition for the treatment of hyperlipidemia comprising an oxintomodulin derivative (application divisional 0177-2015). | |
WO2013067271A3 (en) | Stable dermatological aerosol foams utilizing reactive propellants | |
DOP2013000105A (en) | DERIVATIVES OF 2,3-DIHYDROIMIDAZO [1,2-C] QUINAZOLINA SUBSTITUTED WITH AMINOALCOHOLES THAT ARE USEFUL TO TREAT HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | |
AR097329A1 (en) | REDUCTION OF THE DERIVA DEL ROCIADO | |
WO2013178701A3 (en) | Compositions containing fatty alcohols, cationic surfactants and n-acyl-n-methylglucamines | |
PE20130216A1 (en) | TOPICAL FORMULATION FOR A JAK INHIBITOR | |
RU2016130098A (en) | GEL COMPOSITIONS FOR LOCAL USE, INCLUDING POLYCAPROLACTONE POLYMER, AND WAYS TO IMPROVE LOCAL USE EFFICIENCY | |
AR107967A1 (en) | MODIFIED Hyaluronic Acid, METHOD FOR THEIR PREPARATION AND USES OF THE SAME | |
AR097330A1 (en) | HELPFUL COMBINATION | |
BR112015020049A2 (en) | composition in the form of an oil-in-water emulsion and cosmetic process | |
PE20151759A1 (en) | SUBSTITUTE IMIDAZOPYRIDAZINES | |
NZ735341A (en) | Topical compositions comprising a corticosteroid | |
GB2515696A (en) | Anti-adherent formulation including a quaternary ammonium compound and a fatty alcohol | |
JP2015534980A5 (en) | ||
AR065317A1 (en) | USE OF CHITOSANS, DERIVATIVES OF CHITOSANS AND A PHYSIOLOGICALLY ACCEPTABLE SALT OF THE SAME FOR THE TREATMENT OF UNGUE INFLAMMATORY DISEASES | |
DOP2016000007A (en) | SUBSTITUTED PIRAZOLPIRIDINS | |
MX2021011424A (en) | Topical formulations for delivery of hedgehog inhibitor compounds and use thereof. | |
RU2015116148A (en) | COSMETIC BASIS FOR MAKE-UP FOR SKIN, REMOVED BY WARM WATER | |
MX2015003074A (en) | Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof. | |
PE20212158A1 (en) | AQUEOUS PHARMACEUTICAL COMPOSITION OF ANTI-IL17A ANTIBODY AND ITS USE | |
CL2016002400A1 (en) | Formulation for personal hygiene | |
AR081765A1 (en) | TOPIC PHARMACEUTICAL COMPOSITIONS | |
PH12017500528A1 (en) | External preparation composition containing s-flurbiprofen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |